BEAM

Beam Therapeutics Inc (BEAM)

US
$ 172.29%

Price Chart

Key Statistics

Market Cap
$ 1.82B
P/E Ratio
0.00
Revenue (TTM)
$ 63.58M
Volume
1.13M
52W High
$ 35.25
52W Low
$ 13.53
Dividend Yield
0.00%
Beta
2.35

Technicals

50-Day MA
20.3713
200-Day MA
24.6146
52 Week High
35.25
52 Week Low
13.525

About BEAM

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

Employees
483
Headquarters
Cambridge, MA
CEO
Mr. John M. Evans M.B.A.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg